Optimal high-throughput screening: Practical experimental design and data analysis for genome-scale RNAi research

Optimal High-Throughput Screening: Practical Experimental Design and Data Analysis for Genome-Scale RNAi Research

Volumn , Issue , 2011, Pages 1-220

  Zhang, Xiaohua Douglas ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84924585848     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511973888     Document Type: Book

References (186)

1. L. Acion, J.J. Peterson, S. Temple, S. Arndt. Probabilistic index: an intuitive non-parametric approach to measuring the size of treatment effects. Statistics in Medicine 25 (2006) 591-602.
2. T.W. Anderson, D.A. Darling. Asymptotic theory of certain “goodness-of-fit” criteria based on stochastic processes. Annals of Mathematical Statistics 23 (1952) 193-212.
3. J. Aubert, A. Bar-Hen, J.J. Daudin, S. Robin. Determination of the differentially expressed genes in microarray experiments using local FDR. BMC Bioinformatics 5 (2004) 125.
4. D. Bakan. The test of significance in psychological research. Psychological Bulletin 66 (1966) 423-37.
5. P. Baldi, G.W. Hatfield. DNA Microarrays and Gene Expression. Cambridge, UK, Cambridge University Press, 2002.
6. D.A. Barbie, P. Tamayo, J.S. Boehm, S.Y. Kim, S.E. Moody, I.F. Dunn, A.C. Schinzel, P. Sandy, E. Meylan, C. Scholl, S. Frohling, E.M. Chan, M.L. Sos, K. Michel, C. Mermel, S.J. Silver, B.A. Weir, J.H. Reiling, Q. Sheng, P.B. Gupta, R.C. Wadlow, H. Le, S. Hoersch, B.S. Wittner, S. Ramaswamy, D.M. Livingston, D.M. Sabatini, M. Meyerson, R.K. Thomas, E.S. Lander, J.P. Mesirov, D.E. Root, D.G. Gilliland, T. Jacks, W.C. Hahn. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462 (2009) 108-22.
7. F. Bard, L. Casano, A. Mallabiabarrena, E. Wallace, K. Saito, H. Kitayama, G. Guizzunti, Y. Hu, F. Wendler, R. DasGupta, N. Perrimon, V. Malhotra. Functional genomics reveals genes involved in protein secretion and Golgi organization. Nature 439 (2006) 604-7.
8. G.A. Barkerand, S.L. Diamond. RNA interference screen to identify pathways that enhance or reduce nonviral gene transfer during lipofection. Molecular Therapy 16 (2008) 1602-8.
9. T. Barrett, D.B. Troup, S.E. Wilhite, P. Ledoux, D. Rudnev, C. Evangelista, I.F. Kim, Soboleva, M. Tomashevsky, R. Edgar. NCBI GEO: mining tens of millions of expression profiles - database and tools update. Nucleic Acids Research 35 (2007) D760-5.
10. R.A. Becker, J.M. Chambers, A.R. Wilks. The NewS Language. PacificGrove, CA, Wadsworth & Brooks/Cole, 1988.
11. Y. Benjamini, Y. Hochberg. Controlling the false discovery rate - A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B-Methodological 57 (1995) 289-300.
12. A. Birmingham, E.M. Anderson, A. Reynolds, D. Ilsley-Tyree, D. Leake, Y. Fedorov, S. Baskerville, E. Maksimova, K. Robinson, J. Karpilow, W.S. Marshall, A. Khvorova. 3’ UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nature Methods 3 (2006) 199-204.
13. A. Birmingham, L.M. Selfors, T. Forster, D. Wrobel, C.J. Kennedy, E. Shanks, J. Santoyo- Lopez, D.J. Dunican, A. Long, D. Kelleher, Q. Smith, R.L. Beijersbergen, P. Ghazal, C.E. Shamu. Statistical methods for analysis of high-throughput RNA interference screens. Nature Methods 6 (2009) 569-75.
14. N. Blow. RNAi technologies: a screen whose time has arrived. Nature Methods 5 (2008) 361-6.
15. C.E. Bonferroni. Il calcolo delle assicurazioni su gruppi di teste. In Studi in Onore del Professore Salvatore Ortu Carboni. Rome, Italy, 1935, pp. 13-60.
16. M. Boutros, J. Ahringer. The art and design of genetic screens: RNA interference. Nature Reviews Genetics 9 (2008) 554-66.
17. M. Boutros, L.P. Bras, W. Huber. Analysis of cell-based RNAi screens. Genome Biology 7 (2006) R66.
18. M. Boutros, A.A. Kiger, S. Armknecht, K. Kerr, M. Hild, B. Koch, S.A. Haas, R. Paro, N. Perrimon. Genome-wide RNAi analysis of growth and viability in Drosophila cells. Science 303 (2004) 832-5.
19. A.L. Brass, D.M. Dykxhoorn, Y. Benita, N. Yan, A. Engelman, R.J. Xavier, J. Lieberman, S.J. Elledge. Identification of host proteins required for HIV infection through a functional genomic screen. Science 319S (2008) 921-6.
20. C. Brideau, B. Gunter, B. Pikounis, A. Liaw. Improved statistical methods for hit selection in high-throughput screening. Journal of Biomolecular Screening 8 (2003) 634-47.
21. P. Broberg. Statistical methods for ranking differentially expressed genes. Genome Biology 4 (2003), R41.
22. P. Broberg. A comparative review of estimates of the proportion unchanged genes and the false discovery rate. BMC Bioinformatics 6 (2005) 199.
23. K. Brown, D. Samarsky. RNAi off-targeting: Light at the end of the tunnel. Journal of RNAi and Gene Silencing 2 (2006) 175-7.
24. D. Bumcrot, M. Manoharan, V. Koteliansky, D.W.Y. Sah. RNAi therapeutics: a potential new class of pharmaceutical drugs. Nature Chemical Biology 2 (2006) 711-19.
25. Y. Cao, R.M. Kumar, B.H. Penn, C.A. Berkes, C. Kooperberg, L.A. Boyer, R.A. Young, S.J. Tapscott. Global and gene-specific analyses show distinct roles for Myod and Myog at a common set of promoters. EMBO Journal 25 (2006) 502-11.
26. R.P. Carver. Case against statistical significance testing. Harvard Educational Review 48 (1978) 378-99.
27. P. Cherepanov, G. Maertens, P. Proost, B. Devreese, J. Van Beeumen, Y. Engelborghs, E. De Clercq, Z. Debyser. HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. Journal of Biological Chemistry 278 (2003) 372-81.
28. N.J. Chung, X.D. Zhang, A. Kreamer, L. Locco, P.F. Kuan, S. Bartz, P.S. Linsley, M. Ferrer, B. Strulovici. Median absolute deviation to improve hit selection for genome-scale RNAi screens. Journal of Biomolecular Screening 13 (2008) 149-58.
29. J.D. Church, B. Harris. The estimation of reliability from stress-strength relationships. Technometrics 12 (1970) 49-54.
30. W.S. Cleveland. The Elements of Graphing Data. Summit, NJ, Hobart Press, 1994.
31. W.S. Cleveland, E. Grosse, W.M. Shyu. Local regression models. In: J.M. Chambers and T.J. Hastie (Eds.), Statistical Models in S. Pacific Grove, CA, Wadsworth & Brooks/Cole, 1992.
32. J. Cohen. The statistical power of abnormal-social psychological research: A review. Journal of Abnormal and Social Psychology 65 (1962) 145-53.
33. J. Cohen. Statistical Power Analysis for the Behavioral Sciences. Erlbaum, Hillsdale, NJ, 1988.
34. J. Cohen. The earth is round (P less than.05). American Psychologist 49 (1994) 997-1003.
35. C. Dalmasso, P. Broet, T. Moreau. A simple procedure for estimating the false discovery rate. Bioinformatics 21 (2005) 660-8.
36. R. Davidson, J.Y. Duclos. Statistical inference for stochastic dominance and for the measurement of poverty and inequality. Econometrica 68 (2000) 1435-64.
37. F. Downton. The estimation of Pr(Y < X) in the normal case. Technometrics 15 (1973) 551-8.
38. S. Draghici, P. Khatri, A.L. Tarca, K. Amin, A. Done, C. Voichita, C. Georgescu, R. Romero. A systems biology approach for pathway level analysis. Genome Research 17 (2007) 153-745.
39. B.J. Eastwood, M.W. Farmen, P.W. Iversen, T.J. Craft, J.K. Smallwood, K.E. Garbison, N.W. Delapp, G.F. Smith. The minimum significant ratio: A statistical parameter to characterize the reproducibility of potency estimates from concentration-response assays and estimation by replicate-experiment studies. Journal of Biomolecular Screening 11 (2006) 253-61.
40. C.J. Echeverri, P.A. Beachy, B. Baum, M. Boutros, F. Buchholz, S.K. Chanda, J. Downward, J. Ellenberg, A.G. Fraser, N. Hacohen, W.C. Hahn, A.L. Jackson, A. Kiger, P.S. Linsley, L. Lum, Y. Ma, B. Mathey-Prevot, D.E. Root, D.M. Sabatini, J. Taipale, N. Perrimon, R. Bernards. Minimizing the risk of reporting false positives in large-scale RNAi screens. Nature Methods 3 (2006) 777-9.
41. C.J. Echeverri, N. Perrimon. High-throughput RNAi screening in cultured cells: a user’s guide. Nature Reviews Genetics 7 (2006) 373-84.
42. B. Efron. Large-scale simultaneous hypothesis testing: The choice of a null hypothesis. Journal of the American Statistical Association 99 (2004) 96-104.
43. M. Eisenstein. Quality control. Nature 442 (2006) 1067-70.
44. S.M. Elbashir, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, T. Tuschl. Duplexes of 21-Nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-8.
45. A.S. Espeseth, Q. Huang, A. Gates, M. Xu, Y. Yu, A.J. Simon, X.P. Shi, X.H.D. Zhang, P. Hodor, D.J. Stone, J. Burchard, G. Cavet, S. Bartz, P. Linsley, W.J. Ray, D. Hazuda. A genome wide analysis of ubiquitin ligases in APP processing identifies a novel regulator of BACE1 mRNA levels. Molecular and Cellular Neuroscience 33 (2006) 227-35.
46. Y. Fedorov, E.M. Anderson, A. Birmingham, A. Reynolds, J. Karpilow, K. Robinson, D. Leake, W.S. Marshall, A. Khvorova. Off-target effects by siRNA can induce toxic phenotype. Rna-A Publication of the Rna Society 12 (2006) 1188-96.
47. Y. Fedorov, A. King, E. Anderson, J. Karpilow, D. Ilsley, W. Marshall, A. Khvorova. Different delivery methods - Different expression profiles. Nature Methods 2 (2005) 241.
48. A. Fire, S.Q. Xu, M.K. Montgomery, S.A. Kostas, S.E. Driver, C.C. Mello. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-11.
49. R.A. Fisher. Statistical Methods for Research Workers. Edinburgh, Scotland, Oliver & Boyd, 1941.
50. R.A. Fisher. Statistical Methods for Research Workers. Edinburgh, Scotland, Oliver & Boyd, 1925.
51. E. Galun. RNA Silencing. Singapore, World Scientific, 2005.
52. C. Genovese, L. Wasserman. Operating characteristics and extensions of the false discovery rate procedure. Journal of the Royal Statistical Society Series B-Statistical Methodology 64 (2002) 499-517.
53. G.V. Glass. Primary, secondary, and meta-analysis of research. Educational Researcher 5 (1976) 3-8.
54. T.R. Golub, D.K. Slonim, P. Tamayo, C. Huard, M. Gaasenbeek, J.P. Mesirov, H. Coller, M.L. Loh, J.R. Downing, M.A. Caligiuri, C.D. Bloomfield, E.S. Lander. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 286 (1999) 531-7.
55. S. Goodman. A dirty dozen: Twelve P-value misconceptions. Seminars in Hematology 45 (2008) 135-40.
56. PJ. Green, B.W. Silverman. Nonparametric Regression and Generalized Linear Models: A Roughness Penalty Approach. London, Chapman and Hall, 1994.
57. Z. Guan, B.L. Wu, H.Y. Zhao. Nonparametric estimator of false discovery rate based on Bernstein polynomials. Statistica Sinica 18 (2008) 905-23.
58. B. Gunter, C. Brideau, B. Pikounis, A. Liaw. Statistical and graphical methods for quality control determination of high-throughput screening data. Journal of Biomolecular Screening 8 (2003) 624-633.
59. L. Guttman. What is not what in statistics. Statistician 26 (1977) 81-107.
60. L. Guttman. The illogic of statistical inference for cumulative science. Applied Stochastic Models and Data Analysis 1 (1985) 3-10.
61. I. Hamamoto, Y. Nishimura, T. Okamoto, H. Aizaki, M.Y. Liu, Y. Mori, T. Abe, T. Suzuki, M.M.C. Lai, T. Miyamura, K. Moriishi, Y. Matsuura. Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B. Journal of Virology 79 (2005) 13473-82.
62. S.A. Haney. RNAi and high-content screening in target identification and validation. Idrugs 8 (2005) 997-1001.
63. G.J. Hannon. RNA interference. Nature 418 (2002) 244-51.
64. G.J. Hannon, P.D. Zamore. Small RNAs, big biology: biochemical studies of RNA interference. In: G.J. Hannon (Ed.), A Guide to Gene Silencing. New York, Cold Spring Harbor Laboratory Press, 2003, pp. 87-108.
65. L.L. Harlow, S.A. Mulaik, J.H. Steiger. What If There Were No Significance Tests? Mahwah, NJ, Lawrence Erlbaum Associates, 1997.
66. L.V. Hedges. Distribution theory for Glass’s estimator of effect size and related estimators. Journal of Educational Statistics 6 (1981) 107-28.
67. L.V. Hedges. I. Olkin Statistical Methods for Meta-Analysis. San Diego, CA, Academic Press, 1985.
68. M. Hollander, D. Wolfe. Nonparametric Statistical Methods. New York, John Wiley & Sons, 1999.
69. V. Hornung, M. Guenthner-Biller, C. Bourquin, A. Ablasser, M. Schlee, S. Uematsu, A. Noronha, M. Manoharan, S. Akira, A. de Fougerolles, S. Endres, G. Hartmann. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nature Medicine 11 (2005) 263-70.
70. D. Howe, M. Costanzo, P. Fey, T. Gojobori, L. Hannick, W. Hide, D.P. Hill, R. Kania, M. Schaeffer, S. St Pierre, S. Twigger, O. White, S.Y. Rhee. Big data: The future of biocuration. Nature 455 (2008) 47-50.
71. PJ. Huber. Robust Statistics. New York, Wiley, 1981.
72. C.J. Huberty. A history of effect size indices. Educational and Psychological Measurement 62 (2002) 227-40.
73. C.J. Huberty, L.L. Lowman. Group overlap as a basis for effect size. Educational and Psychological Measurement 60 (2000) 543-63.
74. G. Hutvagner, J. McLachlan, A.E. Pasquinelli, E. Balint, T. Tuschl, P.D. Zamore. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293 (2001) 834-8.
75. J.P.A. Ioannidis. Microarrays and molecular research: noise discovery? Lancet 365 (2005) 454-5.
76. J.P.A. Ioannidis. Why most published research findings are false. Plos Medicine 2 (2005) 696-701.
77. P.W. Iversen, B.J. Eastwood, G.S. Sittampalam, K.L. Cox. Acomparison ofassayperformance measures in screening assays: Signal window, Z factor, and assay variability ratio. Journal of Biomolecular Screening 11 (2006) 247-52.
78. A.L. Jackson, S.R. Bartz, J. Schelter, S.V. Kobayashi, J. Burchard, M. Mao, B. Li, G. Cavet, P.S. Linsley. Expression profiling reveals off-target gene regulation by RNAi. Nature Biotechnology 21 (2003) 635-7.
79. A.L. Jackson, J. Burchard, D. Leake, A. Reynolds, J. Schelter, J. Guo, J.M. Johnson, L. Lim, J. Karpilow, K. Nichols, W. Marshall, A. Khvorova, P.S. Linsley. Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing. RNA-A Publication of the RNA Society 12 (2006) 1197-1205.
80. A.L. Jackson, P.S. Linsley. Noise amidst the silence: off-target effects of siRNAs? Trends in Genetics 20 (2004) 521-4.
81. A.D. Judge, V. Sood, J.R. Shaw, D. Fang, K. McClintock, I. MacLachlan. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nature Biotechnology 23 (2005) 457-62.
82. P.D. Kassner. Discovery of novel targets with high throughput RNA interference screening. Combinatorial Chemistry & High Throughput Screening 11 (2008) 175-84.
83. D. Kevorkov, V. Makarenkov. Statistical analysis of systematic errors in high-throughput screening. Journal ofBiomolecular Screening10 (2005) 557-67.
84. R.E. Kirk. Practical significance: A concept whose time has come. Educational and Psychological Measurement 56 (1996) 746-59.
85. M.E. Kleinman, K. Yamada, A. Takeda, V. Chandrasekaran, M. Nozaki, J.Z. Baffi, R.J.C. Albuquerque, S. Yamasaki, M. Itaya, Y.Z. Pan, B. Appukuttan, D. Gibbs, Z.L. Yang, K. Kariko, B.K. Ambati, T.A. Wilgus, L.A. DiPietro, E. Sakurai, K. Zhang, J.R. Smith, E.W. Taylor, J. Ambati. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 452 (2008) 591-7.
86. R.A. Klinghoffer, J. Frazier, J. Annis, J.D. Berndt, B.S. Roberts, W.T. Arthur, R. Lacson, X.H.D. Zhang, M. Ferrer, R.T. Moon, M.A. Cleary. A lentivirus-mediated genetic screen identifies dihydrofolate reductase (DHFR) as a modulator of b-actinin/GSK3 signaling. PLoSONE 4(2009) e6892.
87. R. Konig, C.Y. Chiang, B.P. Tu, S.F. Yan, P.D. DeJesus, A. Romero, T. Bergauer, A. Orth, U. Krueger, Y. Zhou, S.K. Chanda. A probability-based approach for the analysis of large- scale RNAi screens. Nature Methods 4 (2007) 847-9.
88. R. Konig, Y.Y. Zhou, D. Elleder, T.L. Diamond, G.M.C. Bonamy, J.T. Irelan, C.Y. Chiang, B.P. Tu, P.D. De Jesus, C.E. Lilley, S. Seidel, A.M. Opaluch, J.S. Caldwell, M.D. Weitzman, K.L. Kuhen, S. Bandyopadhyay, T. Ideker, A.P. Orth, L.J. Miraglia, F.D. Bushman, J.A. Young, S.K. Chanda. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135 (2008) 49-60.
89. M. Lagos-Quintana, R. Rauhut, W. Lendeckel, T. Tuschl. Identification of novel genes coding for small expressed RNAs. Science 294 (2001) 853-8.
90. M. Langaas, B.H. Lindqvist, E. Ferkingstad. Estimating the proportion oftrue null hypotheses, with application to DNA microarray data. Journal of the Royal Statistical Society Series B-Statistical Methodology 67 (2005) 555-72.
91. N.C. Lau, L.P. Lim, E.G. Weinstein, D.P. Bartel. An abundant class oftiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294 (2001) 858-62.
92. R.C. Lee, V. Ambros. An extensive class of small RNAs in Caenorhabditis elegans. Science 294 (2001) 862-4.
93. J.G. Liao, Y. Lin, Z.E. Selvanayagam, W.C.J. Shih. A mixture model for estimating the local false discovery rate in DNA microarray analysis. Bioinformatics 20 (2004) 2694-2701.
94. X.Y. Lin, X. Ruan, M.G. Anderson, J.A. McDowell, P.E. Kroeger, S.W. Fesik, Y. Shen. siRNA- mediated off-target gene silencing triggered by a 7 nt complementation. Nucleic Acids Research 33 (2005) 4527-35.
95. M. Llano, D.T. Saenz, A. Meehan, P. Wongthida, M. Peretz, W.H. Walker, W.L. Teo, E.M. Poeschla. An essential role for LEDGF/p75 in HIV integration. Science 314 (2006) 461-4.
96. I. Maeda, Y. Kohara, M. Yamamoto, A. Sugimoto. Large-scale analysis of gene function in Caenorhabditis elegans by high-throughput RNAi. Current Biology 11 (2001) 171-6.
97. G. Maertens, P. Cherepanov, W. Pluymers, K. Busschots, E. De Clercq, Z. Debyser, Y. Engelborghs. LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV- 1 integrase in human cells. Journal of Biological Chemistry. 278 (2003) 33528-39.
98. N. Mahanthappa. Translating RNA interference into therapies for human disease. Pharma- cogenomics 6 (2005) 879-83.
99. N. Malo, J.A. Hanley, S. Cerquozzi, J. Pelletier, R. Nadon. Statistical practice in high- throughput screening data analysis. Nature Biotechnology 24 (2006) 167-75.
100. J.C. Marioni, C.E. Mason, S.M. Mane, M. Stephens, Y. Gilad. RNA-seq: An assessment of technical reproducibility and comparison with gene expression arrays. Genome Research 18 (2008) 1509-17.
101. R.S. Matson. Applying Genomic and Proteomic Microarray Technology in Drug Discovery. Boca Raton, FL, CRC Press, 2005.
102. K.O. Mcgraw, S.P. Wong, A Common Language Effect Size Statistic. Psychological Bulletin 111 (1992) 361-365.
103. J. McLachlan, R.W. Bean, L.B.T. Jones. A simple implementation of a normal mixture approach to differential gene expression in multiclass microarrays. Bioinformatics 22 (2006) 1608-15.
104. J.E. McLean. Improving Education through Action Research: A Guide for Administrators and Teachers. Thousand Oaks, CA, Corwin Press, 1995.
105. P.E.Meehl. Theory-testing in psychology and physics: A methodological paradox. Philosophy of Science 20 (1967) 103-15.
106. P.E. Meehl. Theoretical risks and tabular asterisks - Karl, Ronald, and slow progress of soft psychology. Journal of Consulting and Clinical Psychology 46 (1978) 806-34.
107. S. Michiels, S. Koscielny, C. Hill. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 365 (2005) 488-92.
108. P. Muller, D. Kuttenkeuler, V. Gesellchen, M.P. Zeidler, M. Boutros. Identification of JAK/STAT signalling components by genome-wide RNA interference. Nature 436 (2005) 871-5.
109. Napoli, C. Lemieux, R. Jorgensen. Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant Cell 2 (1990) 279-89.
110. Neter J., M.H. Kutner, C.J. Nachtsheim. Applied Linear Statistical Models. Chicago, McGraw- Hill, 1996.
111. J. Neyman, E.S. Pearson. On the use and interpretation of certain test criteria for purposes of statistical inference, Part I. Biometrika 29A (1928) 175-240.
112. J. Neyman, E.S. Pearson. On the use and interpretation of certain test criteria for purposes of statistical inference, Part II. Biometrika 29A (1928) 263-94.
113. K. Nybakken, S.A. Vokes, T.Y. Lin, A.P. McMahon, N. Perrimon. A genome-wide RNA interference screen in Drosophila melanogaster cells for new components ofthe Hh signaling pathway. Nature Genetics 37 (2005) 1323-32.
114. J. Onwuegbuzie, J.R. Levin. Without supporting statistical evidence, where would reported measures of substantive importance lead? To no good effect. Journal of Modern Applied Statistical Methods 2 (2003) 133-51.
115. B. Owen, K.J. Graswell, D.L. Hanson. Nonparametric upper confidence bounds for P(Y < X) and confidence limits for P(Y < X) when X and Y are normal. Journal of the American Statistical Association 59 (1964) 906-24.
116. J. Park, E. Partridge, P. Cheung, J. Pawling, R. Donovan, J.L. Wrana, J.W. Dennis. Chemical enhancers of cytokine signaling that suppress micro filament turnover and tumor cell growth. Cancer Research 66 (2006) 3558-66.
117. K. Pearson. On the correlation of characters not quantitatively measurable. Philosophical Transactions of the Royal Society of London 195 (1901) 1-47.
118. L. Pelkmans, E. Fava, H. Grabner, M. Hannus, B. Habermann, E. Krausz, M. Zerial. Genome- wide analysis ofhuman kinases in clathrin- and caveolae/raft-mediated endocytosis. Nature 436 (2005) 78-86.
119. P. Pollard. How significant is “significance”? In: G. Keren and C. Lewis (Eds.), A Handbook for Data Analysis in the Behavioral Sciences: Methodological Issues. Hillsdale, NJ, Lawrence Erlbaum Associates, 1993, pp. 449-460.
120. S. Pounds, S.W. Morris. Estimating the occurrence of false positives and false negatives in microarray studies by approximating and partitioning the empirical distribution of p-values. Bioinformatics 19 (2003) 1236-42.
121. G. Randall, A. Grakoui, C.M. Rice. Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proceedings of the National Academy of Sciences of the United States of America 100 (2003) 235-240.
122. B. Reiser, I. Guttman. Statistical-Inference for Pr(Y-Less-Than-X) - the Normal Case. Technometrics 28 (1986) 253-7.
123. D. Riester, F. Wirsching, G. Salinas, M. Keller, M. Gebinoga, S. Kamphausen, C. Merkwirth, R. Goetz, M. Wiesenfeldt, J. Sturzebecher, W. Bode, R. Friedrich, M. Thurk, A. Schwienhorst. Thrombin inhibitors identified by computer-assisted multiparameter design. Proceedings of the National Academy of Sciences of the United States of America 102 (2005) 8597-8602.
124. S. Robin, F. Bar-Hen, J.J. Daudin, L. Pierre. A semi-parametric approach for mixture models: Application to local false discovery rate estimation. Computational Statistics & Data Analysis 51 (2007) 5483-93.
125. D.M. Rom, E. Hwang. Testing for individual and population equivalence based on the proportion of similar responses. Statistics in Medicine 15 (1996) 1489-1505.
126. R. Rosenthal, R.L. Rosnow, D.B. Rubin. Contrasts and Effect Sizes in Behavioral Research. Cambridge, UK, Cambridge University Press, 2000.
127. W.W. Rozeboom. The fallacy of the null-hypothesis significance test. Psychological Bulletin 57(1960) 416-28.
128. G. Ruvkun. Molecular biology - Glimpses of a tiny RNA world. Science 294 (2001) 797-9.
129. F.E. Satterthwaite. An approximate distribution of estimates of variance components. Biometrics Bulletin 2 (1946) 110-14.
130. P.C. Scacheri, O. Rozenblatt-Rosen, N.J. Caplen, T.G. Wolfsberg, L. Umayam, J.C. Lee, C.M. Hughes, K.S. Shanmugam, A. Bhattacharjee, M. Meyerson, F.S. Collins. Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 1892-7.
131. F.L. Schmidt. What do data really mean - Research findings, metaanalysis, and cumulative knowledge in psychology. American Psychologist 47 (1992) 1173-81.
132. F.L. Schmidt. Statistical significance testing and cumulative knowledge in psychology: Implications for training of researchers. Psychological Methods 1 (1996) 115-29.
133. D. Semizarov, L. Frost, A. Sarthy, P. Kroeger, D.N. Halbert, S.W. Fesik. Specificity of short interfering RNA determined through gene expression signatures. Proceedings of the National Academy of Sciences of the United States of America 100 (2003) 6347-52.
134. S. Senn, Testing for individual and population equivalence based on the proportion of similar responses. Statistics in Medicine 16 (1997) 1303-1305.
135. S.S. Shapiro, M.B. Wilk. An analysis of variance test for normality (complete samples). Biometrika 52 (1965) 591-611.
136. J. Shoemaker. Statistical challenges with gene expression studies. Pharmacogenomics 7 (2006) 511-19.
137. O. Snove, T. Holen. Many commonly used siRNAs risk off-target activity. Biochemical and Biophysical Research Communications 319 (2004) 256-63.
138. B. Sonnichsen, L.B. Koski, A. Walsh, P. Marschall, B. Neumann, M. Brehm, A.M. Alleaume, J. Artelt, P. Bettencourt, E. Cassin, M. Hewitson, C. Holz, M. Khan, S. Lazik, C. Martin, B. Nitzsche, M. Ruer, J. Stamford, M. Winzi, R. Heinkel, M. Roder, J. Finell, H. Hantsch, S.J.M. Jones, M. Jones, F. Piano, K.C. Gunsalus, K. Oegema, P. Gonczy, A. Coulson, A.A. Hyman, c.J. Echeverri. Full-genome RNAi profiling of early embryogenesis in Caenorhabditis ele-gans. Nature 434 (2005) 462-9.
139. J.H. Steiger. Beyond the F test: Effect size confidence intervals and tests of close fit in the analysis of variance and contrast analysis. Psychological Methods 9 (2004) 164-82.
140. M.A. Stephens. EDF statistics for goodness of fit and some comparisons. Journal of the American Statistical Association 69 (1974) 730-7.
141. J.A.C. Sterne, G.D. Smith. Sifting the evidence- what’s wrong with significance tests? British Medical Journal 322 (2001) 226-31.
142. R.A. Stine, J.F. Heyse. Non-parametric estimates of overlap. Statistics in Medicine 20 (2001) 215-36.
143. D.J. Stone, S. Marine, J. Majercak, W.J. Ray, A. Espeseth, A. Simon, M. Ferrer. High-throughput screening by RNA interference - Control of two distinct types of variance. Cell Cycle 6(2007) 898-901.
144. J.D. Storey. A direct approach to false discovery rates. Journal of the Royal Statistical Society Series B-Statistical Methodology 64 (2002) 479-98.
145. J.D. Storey. The positive false discovery rate: A Bayesian interpretation and the q-value. The Annals of Statistics 31 (2003) 2013-35.
146. J.D. Storey, R. Tibshirani. Statistical significance for genomewide studies. Proceedings of the National Academy of Sciences of the United States of America 100 (2003) 9440-5.
147. K. Strimmer. A unified approach to false discovery rate estimation. BMC Bioinformatics 9 (2008) 303.
148. Y.X. Sui, Z.J. Wu. Alternative statistical parameter for high-throughput screening assay quality assessment. Journal of Biomolecular Screening 12 (2007) 229-34.
149. A.C. Tamhane, D.D. Dunlop. Statistics and Data Analysis. Upper Saddle River, NJ, Prentice- Hall, 2000.
150. H. Tian, L.C. Cao, Y.P. Tan, S. Williams, L.L. Chen, T. Matray, A. Chenna, S. Moore, V. Hernandez, V. Xiao, M.X. Tang, S. Singh. Multiplex mRNA assay using electrophoretic tags for high-throughput gene expression analysis. Nucleic Acids Research 32 (2004) e126.
151. N.H. Timm. Estimating effect sizes in exploratory experimental studies when using a linear model. American Statistician 58 (2004) 213-17.
152. C.A. Tsai, H.M. Hsueh, J.J. Chen. Estimation of false discovery rates in multiple testing: application to gene microarray data. Biometrics 59 (2003) 1071-81.
153. T. Vacha-Haase, B. Thompson. How to estimate and interpret various effect sizes. Journal of Counseling Psychology 51 (2004) 473-81.
154. W.N. Venables, B.D. Ripley. Modern Applied Statistics with S. New York, Springer, 2002.
155. D.F. Vysochanskij, Y.I. Petunin. Justification ofthe 3-sigma rule for unimodal distribution. Theory of Probability and Mathematical Statistics 21 (1980) 25-36.
156. J.D. Watson, F.H. Crick. Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature 171 (1953) 737-8.
157. F. Wilcoxon. Individual comparisons by ranking methods. Biometrics 1 (1945) 80-3.
158. A.T. Willingham, Q.L. Deveraux, G.M. Hampton, P. Aza-Blanc. RNAi and HTS: exploring cancer by systematic loss-of-function. Oncogene 23 (2004) 8392-8400.
159. J.H. Zhang, T.D.Y. Chung, K.R. Oldenburg. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. Journal of Biomolecular Screening 4(1999) 67-73.
160. J.H. Zhang, T.D.Y. Chung, K.R. Oldenburg. Confirmation of primary active substances from high throughput screening of chemical and biological populations: A statistical approach and practical considerations. Journal of Combinatorial Chemistry 2 (2000) 258-65.
161. X.H.D. Zhang. A new method with flexible and balanced control of false negatives and false positives for hit selection in RNA interference high-throughput screening assays. Journal of Biomolecular Screening 12 (2007) 645-55.
162. X.H.D. Zhang. A pair of new statistical parameters for quality control in RNA interference high-throughput screening assays. Genomics 89 (2007) 552-61.
163. X.H.D. Zhang. New concept of contrast in statistical analysis. The American Statistical Association Proceedings, Alexandria, VA, 2007, pp. 637-648.
164. X.H.D. Zhang. Threshold determination of strictly standardized mean difference in RNA interference high throughput screening assays. IMECS Proceeding (2007) 261-6.
165. X.H.D. Zhang. Genome-wide screens for effective siRNAs through assessing the size of siRNA effects. BMC Research Notes 1 (2008) 33.
166. X.H.D. Zhang. Novel analytic criteria and effective plate designs for quality control in genome-scale RNAi screens. Journal of Biomolecular Screening 13 (2008) 363-77.
167. X.H.D. Zhang. A method for effectively comparing gene effects in multiple conditions in RNAi and expression-profiling research. Pharmacogenomics 10 (2009) 345-58.
168. X.H.D. Zhang. A statistical method assessing collective activity of multiple siRNAs targeting a gene in RNAi screens. Alexandria, VA. The American Statistical Association Proceedings. 2010 (In press).
169. X.H.D. Zhang. An effective method for controlling false discovery and false non-discovery rates in genome-scale RNAi screens. Journal of Biomolecular Screening 15 (2010) 1116-22.
170. X.H.D. Zhang. Assessing the size of gene or RNAi effects in multifactor high-throughput experiments. Pharmacogenomics 11 (2010) 199-213.
171. X.H.D. Zhang. Strictly standardized mean difference, standardized mean difference and classical t-test for the comparison of two groups. Statistics in Biopharmaceutical Research 2 (2010) 292-9.
172. X.H.D. Zhang, A. Espeseth, N. Chung, M. Ferrer. Evaluation of a novel metric for quality control in an RNA interference high-throughput screening assay. Las Vegas, NV, CSREA Press, 2006, pp. 385-390.
173. X.H.D. Zhang, A.S. Espeseth, E.N. Johnson, J. Chin, A. Gates, L.J. Mitnaul, S.D. Marine, J. Tian, E.M. Stec, P. Kunapuli, D.J. Holder, J.F. Heyse, B. Strulovici, M. Ferrer. Integrating experimental and analytic approaches to improve data quality in genome-wide RNAi screens. Journal ofBiomolecular Screening 13 (2008) 378-89.
174. X.H.D. Zhang, M. Ferrer, A.S. Espeseth, S.D. Marine, E.M. Stec, M.A. Crackower, D.J. Holder, J.F. Heyse, B. Strulovici. The use of strictly standardized mean difference for hit selection in primary RNA interference high-throughput screening experiments. Journal of Biomolecular Screening 12 (2007) 497-509.
175. X.H.D. Zhang, J.F. Heyse. Determination of sample size in genome-scale RNAi screens. Bioinformatics 25 (2009) 841-4.
176. X.H.D. Zhang, P.F. Kuan, M. Ferrer, X.H. Shu, Y.C.X. Liu, A.T. Gates, P. Kunapuli, E.M. Stec, M. Xu, S.D. Marine, D.J. Holder, B. Strulovici, J.F. Heyse, A.S. Espeseth. Hit selection with false discovery rate control in genome-scale RNAi screens. Nucleic Acids Research 36 (2008) 4667-79.
177. X.H.D. Zhang, R. Lacson, R. Yang, S. Marine, A. McCampbell, D. Toolan, T. Hare, J. Kajdas, D.J. Holder, J.F. Heyse, M. Ferrer. The use of SSMD-based false discovery and false nondiscovery rates in genome-scale RNAi screens. Journal of Biomolecular Screening 15 (2010) 1123-31.
178. X.H.D. Zhang, S.D. Marine, M. Ferrer. Error rates andpowers in genome-scale RNAi screens. Journal of Biomolecular Screening 14 (2009) 230-8.
179. X.H.D. Zhang, X.C. Yang, N. Chung, A. Gates, E. Stec, P. Kunapuli, D.J. Holder, M. Ferrer, A. Espeseth. Exploring statistical methods for hit selection in RNA interference high throughput screening experiments. The American Statistical Association Proceedings, 2005, pp. 775-80.
180. X.H.D. Zhang, X.C. Yang, N.J. Chung, A. Gates, E. Stec, P. Kunapuli, D.J. Holder, M. Ferrer, A.S. Espeseth. Robust statistical methods for hit selection in RNA interference high-throughput screening experiments. Pharmacogenomics 7 (2006) 299-309.
181. H.F. Zhao, D. L’Abbe, N. Jolicoeur, M.Q. Wu, Z. Li, Z.B. Yu, S.H. Shen. High-throughput screening of effective siRNAs from RNAi libraries delivered via bacterial invasion. Nature Methods 2 (2005) 967-73.
182. W.Q. Zhao, F. Santini, R. Breese, D. Ross, X.H.D. Zhang, D.J. Stone, M. Ferrer, M. Townsend, A.L. Wolfe, M.A. Seager, G.G. Kinney, PJ. Shughrue, W.J. Ray. Inhibition of calcineurin- mediated endocytosis and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid beta oligomer-induced synaptic disruption. Journal of Biological Chemistry 285 (2010) 7619-32.
183. H.L. Zhou, M. Xu, Q. Huang, A.T. Gates, X.H.D. Zhang, J.C. Castle, E. Stec, M. Ferrer, A.Strulovici, D.J. Hazuda, A.S. Espeseth. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host & Microbe 4 (2008) 495-504.
184. W. Zhou. Statistical inference for P(X < Y). Statistics in Medicine 27 (2008) 257-79.
185. P. Zuck, E.M. Murray, E. Stec, J.A. Grobler, A.J. Simon, B. Strulovici, J. Inglese, O.A. Flores, M. Ferrer. A cell-based beta-lactamase reporter gene assay for the identification of inhibitors of hepatitis C virus replication. Analytical Biochemistry 334 (2004) 344-55.
186. Anon. A billion dollar punt. Nature Biotechnology 24 (2006) 1453.